Migraine and Menstrual Cycle Synchrony in Females
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Menstrually Related and Nonmenstrual Migraines in A
MENSTRUALLY RELATED AND NONMENSTRUAL MIGRAINES IN A FREQUENT MIGRAINE POPULATION: FEATURES, CORRELATES, AND ACUTE TREATMENT DIFFERENCES A dissertation presented to the faculty of the College of Arts and Sciences of Ohio University In partial fulfillment of the requirements for the degree Doctor of Philosophy Brenda F. Pinkerman March 2006 This dissertation entitled MENSTRUALLY RELATED AND NONMENSTRUAL MIGRAINES IN A FREQUENT MIGRAINE POPULATION: FEATURES, CORRELATES, AND ACUTE TREATMENT DIFFERENCES by BRENDA F. PINKERMAN has been approved for the Department of Psychology and the College of Arts and Sciences by Kenneth A. Holroyd Distinguished Professor of Psychology Benjamin M. Ogles Interim Dean, College of Arts and Sciences PINKERMAN, BRENDA F. Ph.D. March 2006. Clinical Psychology Menstrually Related and Nonmenstrual Migraines in a Frequent Migraine Population: Features, Correlates, and Acute Treatment Differences (307 pp.) Director of Dissertation: Kenneth A. Holroyd This research describes and compares menstrually related migraines as defined by recent proposed guidelines of the International Headache Society (IHS, 2004) to nonmenstrual migraines in a population of female migraineurs with frequent, disabling migraines. Migraines are compared by frequency per day of the menstrual cycle, headache features, use of abortive and rescue medications, and acute migraine treatment outcomes. In addition, this study explores predictors of acute treatment response and headache recurrence within 24 hours following acute migraine treatment for menstrually related migraines. Participants are 107 menstruating female migaineurs who met IHS (2004) proposed criteria for menstrually related migraines and completed headache diaries using hand-held computers. Diary data are analyzed using repeated measures logistic regression. The frequency of migraines is significantly increased during the perimenstrual period, and menstrually related migraines are of longer duration and greater frequency with longer lasting disability than nonmenstrual migraines. -
Migraine: Spectrum of Symptoms and Diagnosis
KEY POINT: MIGRAINE: SPECTRUM A Most patients develop migraine in the first 3 OF SYMPTOMS decades of life, some in the AND DIAGNOSIS fourth and even the fifth decade. William B. Young, Stephen D. Silberstein ABSTRACT The migraine attack can be divided into four phases. Premonitory phenomena occur hours to days before headache onset and consist of psychological, neuro- logical, or general symptoms. The migraine aura is comprised of focal neurological phenomena that precede or accompany an attack. Visual and sensory auras are the most common. The migraine headache is typically unilateral, throbbing, and aggravated by routine physical activity. Cutaneous allodynia develops during un- treated migraine in 60% to 75% of cases. Migraine attacks can be accompanied by other associated symptoms, including nausea and vomiting, gastroparesis, di- arrhea, photophobia, phonophobia, osmophobia, lightheadedness and vertigo, and constitutional, mood, and mental changes. Differential diagnoses include cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoenphalopathy (CADASIL), pseudomigraine with lymphocytic pleocytosis, ophthalmoplegic mi- graine, Tolosa-Hunt syndrome, mitochondrial disorders, encephalitis, ornithine transcarbamylase deficiency, and benign idiopathic thunderclap headache. Migraine is a common episodic head- (Headache Classification Subcommittee, ache disorder with a 1-year prevalence 2004): of approximately 18% in women, 6% inmen,and4%inchildren.Attacks Recurrent attacks of headache, consist of various combinations of widely varied in intensity, fre- headache and neurological, gastrointes- quency, and duration. The attacks tinal, and autonomic symptoms. Most are commonly unilateral in onset; patients develop migraine in the first are usually associated with an- 67 3 decades of life, some in the fourth orexia and sometimes with nausea and even the fifth decade. -
Hormonal Contraceptive Treatment May Reduce the Risk of Fibromyalgia in Women with Dysmenorrhea: a Cohort Study
Journal of Personalized Medicine Article Hormonal Contraceptive Treatment May Reduce the Risk of Fibromyalgia in Women with Dysmenorrhea: A Cohort Study Cheng-Hao Tu 1,* , Cheng-Li Lin 2, Su-Tso Yang 3,4, Wei-Chih Shen 5,6 and Yi-Hung Chen 1,7,8,* 1 Graduate Institute of Acupuncture Science, China Medical University, Taichung 404333, Taiwan 2 Management Office for Health Data, China Medical University Hospital, Taichung 404332, Taiwan; [email protected] 3 Department of Medical Imaging, China Medical University Hospital, Taichung 404332, Taiwan; [email protected] 4 School of Chinese Medicine, China Medical University, Taichung 404333, Taiwan 5 Center of Augmented Intelligence in Healthcare, China Medical University Hospital, Taichung 404332, Taiwan; [email protected] 6 Department of Computer Science and Information Engineering, Asia University, Taichung 413305, Taiwan 7 Traditional Chinese Medicine Research Center, China Medical University, Taichung 404333, Taiwan 8 Department of Photonics and Communication Engineering, Asia University, Taichung 41354, Taiwan * Correspondence: [email protected] (C.-H.T.); [email protected] (Y.-H.C.); Tel.: +886-4-22053366 (C.-H.T.) (ext. 3336) Received: 17 November 2020; Accepted: 11 December 2020; Published: 14 December 2020 Abstract: Dysmenorrhea is the most common gynecological disorder for women in the reproductive age. Study has indicated that dysmenorrhea might be a general risk factor of chronic pelvic pain and even chronic non-pelvic pain, such as fibromyalgia. We used the Longitudinal Health Insurance Database 2000 from the Taiwan National Health Research Institutes Database to investigate whether women with dysmenorrhea have a higher risk of fibromyalgia and whether treatment of dysmenorrhea reduced the risk of fibromyalgia. -
Re-Cycling the Menstrual Cycle: a Multidisciplinary Reinterpretation of Menstruation
Western Michigan University ScholarWorks at WMU Master's Theses Graduate College 12-1998 Re-Cycling the Menstrual Cycle: A Multidisciplinary Reinterpretation of Menstruation Heather H. Rea Follow this and additional works at: https://scholarworks.wmich.edu/masters_theses Part of the Anthropology Commons Recommended Citation Rea, Heather H., "Re-Cycling the Menstrual Cycle: A Multidisciplinary Reinterpretation of Menstruation" (1998). Master's Theses. 3942. https://scholarworks.wmich.edu/masters_theses/3942 This Masters Thesis-Open Access is brought to you for free and open access by the Graduate College at ScholarWorks at WMU. It has been accepted for inclusion in Master's Theses by an authorized administrator of ScholarWorks at WMU. For more information, please contact [email protected]. RE-CYCLING THE MENSTRUAL CYCLE: A MULTIDISCIPLINARY REINTERPRETATION OF MENSTRUATION by Heather H. Rea A Thesis Submitted to the Faculty of The Graduate College in partial fulfillment of the requirements for the Degree of Master of Arts Department of Anthropology Western Michigan University Kalamazoo, Michigan December 1998 Copyright by Heather H. Rea 1998 ACKNOWLEDGMENTS I would like to thank my thesis committee, Dr. Robert Anemone, Dr. David Karowe, and Dr. Erika Loeffler. Without their combined patience, insights, and senses of humor, this thesis would not have been completed. I would especially like to thank Dr. Loeffler who has been a supportive and inspirational boss, teacher, and friend throughout my graduate work. I would like to thank Marc Rea who suffered through the early stages of this thesis and my graduate work. He also suffered with me through our long-lost-psychotic-puppy's diaper-wearing first cycle of heat which inspired everything. -
Migraine Headache Prophylaxis Hien Ha, Pharmd, and Annika Gonzalez, MD, Christus Santa Rosa Family Medicine Residency Program, San Antonio, Texas
Migraine Headache Prophylaxis Hien Ha, PharmD, and Annika Gonzalez, MD, Christus Santa Rosa Family Medicine Residency Program, San Antonio, Texas Migraines impose significant health and financial burdens. Approximately 38% of patients with episodic migraines would benefit from preventive therapy, but less than 13% take prophylactic medications. Preventive medication therapy reduces migraine frequency, severity, and headache-related distress. Preventive therapy may also improve quality of life and prevent the progression to chronic migraines. Some indications for preventive therapy include four or more headaches a month, eight or more headache days a month, debilitating headaches, and medication- overuse headaches. Identifying and managing environmental, dietary, and behavioral triggers are useful strategies for preventing migraines. First-line med- ications established as effective based on clinical evidence include divalproex, topiramate, metoprolol, propranolol, and timolol. Medications such as ami- triptyline, venlafaxine, atenolol, and nadolol are probably effective but should be second-line therapy. There is limited evidence for nebivolol, bisoprolol, pindolol, carbamazepine, gabapentin, fluoxetine, nicardipine, verapamil, nimodipine, nifedipine, lisinopril, and candesartan. Acebutolol, oxcarbazepine, lamotrigine, and telmisartan are ineffective. Newer agents target calcitonin gene-related peptide pain transmission in the migraine pain pathway and have recently received approval from the U.S. Food and Drug Administration; how- ever, more studies of long-term effectiveness and adverse effects are needed. The complementary treatments petasites, feverfew, magnesium, and riboflavin are probably effective. Nonpharmacologic therapies such as relaxation training, thermal biofeedback combined with relaxation training, electromyographic feedback, and cognitive behavior therapy also have good evidence to support their use in migraine prevention. (Am Fam Physician. 2019; 99(1):17-24. -
Effects of the Menstrual Cycle on Medical Disorders
REVIEW ARTICLE Effects of the Menstrual Cycle on Medical Disorders Allison M. Case, MD; Robert L. Reid, MD xacerbation of certain medical conditions at specific phases of the menstrual cycle is a well-recognized phenomenon. We review the effects of the menstrual cycle on medical conditions, including menstrual migraine, epilepsy, asthma, rheumatoid arthritis, irritable bowel syndrome, and diabetes. We discuss the role of medical suppression of ovulationE using gonadotropin-releasing hormone agonists in the evaluation and treatment of these disorders. Peer-reviewed publications from English-language literature were located via MEDLINE or from bibliographies of relevant articles. We reviewed all review articles, case reports and series, and therapeutic trials. Emphasis was placed on diagnosis and therapy of menstrual cycle– related exacerbations of disease processes. Abrupt changes in the concentrations of circulating ovar- ian steroids at ovulation and premenstrually may account for menstrual cycle–related changes in these chronic conditions. Accurate documentation of symptoms on a menstrual calendar allows identification of women with cyclic alterations in disease activity. Medical suppression of ovula- tion using gonadotropin-releasing hormone agonists can be useful for both diagnosis and treat- ment of any severe, recurrent menstrual cycle–related disease exacerbations. Arch Intern Med. 1998;158:1405-1412 The menstrual cycle, an event that punctu- Several theories have been proposed to ates the lives of most women, may be asso- explain these menstrual cycle–related effects ciated with diverse physical, psychological, on existing disease processes, including fluc- and behavioral changes. Not surprisingly, it tuations in levels of sex steroids, cyclic alter- plays a significant role in women’s health and ations in the immune system, and changing disease. -
Female Reproductive Strategies and the Ovarian Cycle in Hamadryas
Femalereproductivestrategiesandtheovarian cycleinhamadryasbaboons AthesissubmittedinpartialrequirementoftheMaster’sDegreeof ScienceinConservationBiologyatVictoriaUniversityofWellington by R.E.Tobler ABSTRACT: Thisthesisexaminestherelationshipbetweensexualbehaviourandthe ovarian cycle in a group-living primate, Papio h. hamadryas . Of particular interest is whetherfemalesmodifytheirovariancycleinamannerthatisexpectedincreasetheir reproductivesuccess.Thestudywasconductedonacaptivecolonywheretheresident males (RM) had been vasectomised prior to start of the study resulting in all mature femalesundergoingrepeatedovariancyclingthroughoutthestudyperiod.Thismadethe analysisofsexualbehaviourrelativetofinescalechangesintheovariancyclepossible. One year of ovarian cycle data and 280 hours of behavioural data was collected via observationalsamplingduringthestudy.RMvasectomisationdidnotalterthearchetypal one male unit social structure nor the typical socio-spatial organisation of wild hamadryas populations. Females were found to be more promiscuous than in wild populations, however, presumably because of the confounding effect that the high number of simultaneously cycling females had on RM herding (Chapter 1). RMs dominatedcopulationsovertheoptimalconceptiveperiodoftheovariancycle,whilethe majorityofextra-OMUcopulationsoccurredoutsidethisperiodandwererarelysolicited by females. This pattern supports a dual paternity concentration/paternity confusion strategy,andnotfemalechoiceorfertilityinsurancestrategies(Chapter2).Femaleswere not found to synchronise -
Migraine and Tension Headache Guideline
Migraine and Tension Headache Guideline Major Changes as of May 2021 .................................................................................................................... 2 Medications Not Recommended for Headache Treatment .......................................................................... 2 Background ................................................................................................................................................... 2 Diagnosis Red flag warning signs ........................................................................................................................... 3 Differential diagnosis .............................................................................................................................. 3 Imaging ................................................................................................................................................... 3 Migraine versus tension headache ......................................................................................................... 4 Medication overuse headache ................................................................................................................ 4 Menstruation-related migraine ................................................................................................................ 4 Tension Headache Acute treatment ...................................................................................................................................... 5 Prophylaxis ............................................................................................................................................ -
For Headache
*** Drug Safety Alert *** May 6, 2013, the U.S. Food and Drug Administration (FDA) advised health care professionals and women that the anti-seizure medication valproate sodium and related products, valproic acid and divalproex sodium, are contraindicated and should not be taken by pregnant women for the prevention of migraine headaches. Based on information from a recent study, there is evidence that these medications can cause decreased IQ scores in children whose mothers took them while pregnant. Stronger warnings about use during pregnancy will be added to the drug labels, and valproate’s pregnancy category for migraine use will be changed from "D" (the potential benefit of the drug in pregnant women may be acceptable despite its potential risks) to "X" (the risk of use in pregnant women clearly outweighs any possible benefit of the drug). Valproate products will remain in pregnancy category D for treating epilepsy and manic episodes associated with bipolar disorder. BACKGROUND: Valproate products are approved for the treatment of certain types of epilepsy, the treatment of manic episodes associated with bipolar disorder, and the prevention of migraine headaches. They are also used off-label (for uses not approved by FDA) for other conditions, particularly other psychiatric conditions. This alert is based on the final results of the Neurodevelopmental Effects of Antiepileptic Drugs (NEAD) study showing that children exposed to valproate products while their mothers were pregnant had decreased IQs at age 6 compared to children exposed to other anti-epileptic drugs. For additional details, see the Drug Safety Communication Data Summary section. RECOMMENDATION: Valproate products should not be used in pregnant women for prevention of migraine headaches and should be used in pregnant women with epilepsy or bipolar disorder only if other treatments have failed to provide adequate symptom control or are otherwise unacceptable. -
Headaches in Woman
11 Headaches in Women Randolph W. Evans Women have headaches more commonly than men. The preva- lence of migraine is 18% of women and 6% of men. This gender ratio increases from menarche, peaks at 42 years of age, and then declines. For young women the incidence of migraine with aura peaks between the ages of 12 and 13 (14.1/1,000 person- years), and migraine without aura peaks between the ages of 14 and 17 (18.9/1,000 person-years) (1). Table 11-1 provides the life- time prevalence of various headaches in women and men. Estrogen levels are a key factor in the increased prevalence of migraine in women. Evidence includes the following: migraine prevalence increases at menarche; estrogen withdrawal during menstruation is a common migraine trigger; estrogen administra- tion in oral contraceptives and hormone replacement therapy can trigger migraines; migraines typically decrease during the second and third trimesters of pregnancy, when estrogen levels are high; migraines are common immediately postpartum, with the precipi- tous drop in estrogen levels; and migraines generally improve with physiological menopause. Exactly how changes in estrogen levels influence migraine is not understood. Among numerous effects, fluctuations in estrogen levels can result in changes in prostaglandins and the uterus, prolactin release, opioid regula- tion, and melatonin secretion. These fluctuations can also cause changes in neurotransmitters, including the catecholamines, noradrenaline, serotonin, dopamine, and endorphins (2). This chapter reviews some important headache issues for women, including menstrual migraine, menopause and migraine, oral contraceptive use in migraineurs, and headaches during pregnancy and postpartum. MENSTRUAL MIGRAINE The reported prevalence of menstrual migraine varies from 4% to 73%, depending on the criteria used for the timing of the attack. -
Loss of Oestrus and Concealed Ovulation in Human Evolution
Current Anthropology Volume 40, Number 3, June 1999 1999 by The Wenner-Gren Foundation for Anthropological Research. All rights reserved 0011-3204/99/4003-0001 $2.50 The rich literature on the sexual behaviour of the Ho- mininae (Australopithecus and Homo) emphasizes the Loss of Oestrus and uniqueness in this regard of Homo sapiens and attri- butes considerable importance to the role of sexual be- haviour in the process of hominization and even in the Concealed Ovulation evolutionary success of the species (e.g., Morris 1967, Alexander and Noonan 1979, Lovejoy 1981, Kourtovik in Human Evolution 1983, Parker 1987, Turke 1988). The absence of signs of ovulation and the accompanying so-called constant receptivity in human females are considered fundamen- tal. The uniqueness of their emergence in the evolution The Case against the Sexual- of the Hominoidea is assumed on the basis of the chim- panzee model. This assumption has produced many Selection Hypothesis hypotheses as to the evolutionary causes of various forms of sexual signaling and behaviour allegedly char- acteristic of the Plio/Pleistocene evolution of the Ho- by Bogusøaw Pawøowski mininae. The adaptive advantage of constant receptiv- ity has been suggested to be greater cooperation within the group and reduction of competitiveness among males (Etkin 1963, Pfeiffer 1969, Fox 1972, Daniels 1983), the emergence of monogamy (Etkin 1954, Morris The assumption that absence of oestrus and of manifestations of 1967, Lovejoy 1981), the intensi®cation of paternal be- ovulation is speci®c to humans has given rise to various propos- als of a role for selection pressures in the evolution of these fea- haviour (Alexander and Noonan 1979; Symons 1979; tures in the form of sexual selection or other behavioural adapta- Strassmann 1981; Turke 1984, 1988), the possibility of tions. -
Menstrual Synchrony: Fact Or Artifact?
Menstrual Synchrony: Fact or Artifact? Anna Ziomkiewicz Polish Academy of Sciences Although more than thirty years of intensive investigation have passed since McClintock first published results on menstrual synchrony, there is still no conclu- sive evidence for the existence of this phenomenon. Indeed, a growing body of null- result studies, critiques of menstrual synchrony studies, and the lack of convincing evolutionary explanations bring into question the existence of this phenomenon. This paper presents results of a study conducted over five consecutive months in Polish student dormitories. In 18 pairs and 21 triples of college-age women, men- strual synchrony was not found. Social interactions, considered the most important factor mediating the effect of menstrual synchrony, was unrelated to any difference in menstrual cycle onsets. Initial menstrual onset difference was influenced by woman's body mass and menstrual cycle irregularity. These results provide further evidence that women do not synchronize their menstrual cycles. KEY WORDS: Menstrual cycle; Menstrual synchrony; Social interactions artha McClintock (197 l) first reported the apparent influence of social inter- M actions on menstrual cycles of women living in a college dormitory. In that study, 135 women, age 17 to 22, living in single or double rooms, were asked to recall (a) their last and second to last menstrual period three times during the school year, (b) time spent each week in the company of men, and (c) the list of girls they consider their best friends. Statistically significant effects of menstrual synchrony were reported for pairs of friends and groups of friends, which subsequently led to more than thirty years of intensive interest in the phenomenon of menstrual syn- chrony and its mechanisms.